1. Definition of responder: introduction

   • Giancarlo Comi

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 209 - 210

2. Clinical markers of therapeutic response to disease modifying drugs

   • Carlo Pozzilli
   • Luca Prosperini

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 211 - 213

3. Definition of non-responders: biological markers

   • Roberto Furlan

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 214 - 215

4. Interferon-beta responders and non-responders. A biological approach

   • Antonio Bertolotto
   • Francesca Gilli

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 216 - 217

5. Neurophysiological markers

   • Letizia Leocani
   • Giancarlo Comi

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 218 - 221

6. The definition of non-responder to multiple sclerosis treatment: neuroimaging markers

   • Marco Rovaris

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 222 - 224

7. Postmarketing evidence of disease-modifying drugs in multiple sclerosis

   • Maria Trojano
   • Damiano Paolicelli
   • Mariangela D’Onghia

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 225 - 226

8. Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients

   • Marco Capobianco
   • Annalisa Rizzo
   • Antonio Bertolotto

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 227 - 229

9. Induction and add-on therapy with Mitoxantrone and Interferon beta in multiple sclerosis

   • Mauro Zaffaroni
   • Annalisa Rizzo
   • Giancarlo Comi

   Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 230 - 232

10. Cyclophosphamide-based combination therapies for autoimmunity

    • Paola Perini
    • Massimiliano Calabrese
    • Paolo Gallo

    Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 233 - 234

11. Natalizumab: a country-based surveillance program

    • Gian Luigi Mancardi
    • Maria Pia Amato
    • Nello Martini

    Multiple Sclerosis: The Management of Non-Responders 09 August 2008 Pages: 235 - 237

12. Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue

    • Joke S. Kalkman
    • Machiel J. Zwarts
    • Gijs Bleijenberg

    Updates in Clinical Neurology 09 August 2008 Pages: 238 - 240

13. Physiopathology of fatigue in Multiple Sclerosis

    • Letizia Leocani
    • Bruno Colombo
    • Giancarlo Comi

    Updates in Clinical Neurology 09 August 2008 Pages: 241 - 243

14. Frequency, characterisation and therapies of fatigue after stroke

    • Jean-Marie Annoni
    • Fabienne Staub
    • Andrea Brioschi

    Updates in Clinical Neurology 09 August 2008 Pages: 244 - 246

15. The treatment of fatigue

    • Alfredo Romani

    Updates in Clinical Neurology 09 August 2008 Pages: 247 - 249

16. Induction vs. escalation of therapy for relapsing Multiple Sclerosis: the evidence

    • Mark S. Freedman

    Updates in Clinical Neurology 09 August 2008 Pages: 250 - 252

17. Induction vs. escalating therapy in Multiple Sclerosis: practical implications

    • Giancarlo Comi

    Updates in Clinical Neurology 09 August 2008 Pages: 253 - 255

18. Epidemiological, clinical, and therapeutic aspects of primary intracerebral hemorrhage

    • Alfonso Ciccone
    • Mario Pozzi
    • Roberto Sterzi

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 256 - 257

19. Intracerebral hemorrhage and hypertension

    • Maria Sessa

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 258 - 259

20. Cerebral amyloid angiopathy-related hemorrhages

    • Alessandro Pezzini
    • Alessandro Padovani

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 260 - 263

21. Intracerebral haemorrhage in primary and metastatic brain tumours

    • Andrea Salmaggi
    • Alessandra Erbetta
    • Bianca Pollo

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 264 - 265

22. Warfarin-associated intracerebral hemorrhage

    • Anna Cavallini
    • Simona Fanucchi
    • Alessandra Persico

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 266 - 268

23. Drug abuse and intracranial hemorrhage

    • Mario Pozzi
    • Daria Roccatagliata
    • Roberto Sterzi

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 269 - 270

24. Intracerebral hemorrhage: medical treatment

    • Paola Santalucia

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 271 - 273

25. Management of nontraumatic intracranial hemorrhage

    • Gian Piero Tonnarelli
    • Matteo Minotti
    • Paolo Roccucci

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 274 - 276

26. Renin-angiotensin system and stroke

    • Simona Marcheselli
    • Giuseppe Micieli

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 277 - 278

27. Imaging of cranio-meningeal infectious and inflammatory involvement

    • Giorgio Minonzio
    • Massimo Paolucci Colico
    • Davide Zarcone

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 279 - 282

28. Application of molecular tools for the diagnosis of central nervous system infections

    • Serena Delbue
    • Sara Tremolada
    • Pasquale Ferrante

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 283 - 285

29. Acute disseminated encephalomyelitis

    • Enrico Marchioni
    • Eleonora Tavazzi
    • Sabrina Ravaglia

    Annual Meeting of SIN/SNO Lombardia 09 August 2008 Pages: 286 - 288